BN 52063

Known as: BN-52063 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-1990
02419861990

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Cisplatin (DDP) is an effective anticancer agent that has been successfully applied against various solid tumors. However, DDP… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1991
1991
The present study was undertaken to evaluate the effects of platelet activating factor (PAF) antagonists on nephrotoxicity… (More)
Is this relevant?
1990
1990
1. The effects of a specific PAF acether antagonist (BN 52063) on the response to isocapnic hyperventilation with dry cold air… (More)
Is this relevant?
1990
1990
In a randomised single-blind crossover study we assessed the effects of a specific PAF acether antagonist, BN 52063, on the early… (More)
Is this relevant?
1989
1989
Xenotransplantation between different species may possibly solve some of the difficulties associated with human donor organ… (More)
Is this relevant?
1988
1988
Platelet-activating factor (PAF-acether) is a potent agonist (EC50: 3.2 x 10(-8) M) of isolated rat portal vein. BN 52063… (More)
Is this relevant?
1988
1988
Antigen challenge of ovalbumin (OA)-sensitized guinea pigs results in significant (p less than 0.05) increases in vascular… (More)
Is this relevant?
1987
1987
Antagonism of the effects of platelet activating factor (PAF) by the ginkgolide mixture BN 52063 was assessed in a double-blind… (More)
Is this relevant?
1987
1987
Platelet Activating Factor, PAF-acether, elicits acute and more prolonged inflammatory responses in both experimental animals and… (More)
Is this relevant?
1987
1987
Since proteolytic enzymes play a key role in endotoxaemia and anaphylaxis, diseases in which PAF-acether may be involved, we have… (More)
Is this relevant?